Nausea and vomiting secondary prevention

Revision as of 03:21, 21 January 2021 by Tayebah Chaudhry (talk | contribs) (→‎Secondary prevention)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Nausea and vomiting Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nausea and Vomiting from other Conditions

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nausea and vomiting secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nausea and vomiting secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nausea and vomiting secondary prevention

CDC on Nausea and vomiting secondary prevention

Nausea and vomiting secondary prevention in the news

Blogs on Nausea and vomiting secondary prevention

Directions to Hospitals Treating Nausea and vomiting

Risk calculators and risk factors for Nausea and vomiting secondary prevention

Overview

Secondary prevention

References

  1. 1.0 1.1 Tsakiridis I, Mamopoulos A, Athanasiadis A, Dagklis T (March 2019). "The Management of Nausea and Vomiting of Pregnancy: Synthesis of National Guidelines". Obstet Gynecol Surv. 74 (3): 161–169. doi:10.1097/OGX.0000000000000654. PMID 31634919.
  2. Joulaeerad N, Ozgoli G, Hajimehdipoor H, Ghasemi E, Salehimoghaddam F (2018). "Effect of Aromatherapy with Peppermint Oil on the Severity of Nausea and Vomiting in Pregnancy: A Single-blind, Randomized, Placebo-controlled trial". J Reprod Infertil. 19 (1): 32–38. PMC 5960050. PMID 29850445.
  3. Matthews A, Haas DM, O'Mathúna DP, Dowswell T (September 2015). "Interventions for nausea and vomiting in early pregnancy". Cochrane Database Syst Rev (9): CD007575. doi:10.1002/14651858.CD007575.pub4. PMC 7196889 Check |pmc= value (help). PMID 26348534.
  4. Hu J, Shen Y, Zhang G, He J, Sun M, Zhang H, Hua B, Zheng H (September 2019). "Effect of acupoint therapies on chemotherapy-induced nausea and vomiting: A systematic review protocol". Medicine (Baltimore). 98 (37): e17109. doi:10.1097/MD.0000000000017109. PMC 6750289 Check |pmc= value (help). PMID 31517844.
  5. Elvir-Lazo OL, White PF, Yumul R, Cruz Eng H (2020). "Management strategies for the treatment and prevention of postoperative/postdischarge nausea and vomiting: an updated review". F1000Res. 9. doi:10.12688/f1000research.21832.1. PMC 7429924 Check |pmc= value (help). PMID 32913634 Check |pmid= value (help).
  6. Karthaus M, Schiel X, Ruhlmann CH, Celio L (July 2019). "Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults". Expert Rev Clin Pharmacol. 12 (7): 661–680. doi:10.1080/17512433.2019.1621162. PMID 31194593.

Template:WH Template:WS